What is MapLight Therapeutics, Inc. 's PP&E (net)?

MapLight Therapeutics, Inc. (MPLT) reported PP&E (net) of $968K in Q1 2026.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

MapLight Therapeutics, Inc. MPLT PP&E (Net)

PP&E (Net) at other companies

Bristol-Myers SquibbBMY

$7.66B+6.2%

Johnson & JohnsonJNJ

$23.27B+11.5%

Neurocrine BiosciencesNBIX

$90.9M+4.5%

Acadia PharmaceuticalsACAD

$14.65M+319%

AbbVieABBV

$5.69B+8.6%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$1.53M—

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Market cap$1.39B+100%

Enterprise value$1.34B—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity0×—

Current ratio22.9×—

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's PP&E (net)?: MapLight Therapeutics, Inc. (MPLT) reported PP&E (net) of $968K in Q1 2026.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.